His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.
Scientists at deCODE genetics and collaborators have published a study in the Journal of Allergy and Clinical Immunology ...
"Tivic hits enrolment target for vagus nerve stimulation trial" was originally created and published by Medical Device ...
Scientists at deCODE genetics, a subsidiary of Amgen, and collaborators have published a study in Journal of Allergy and ...
The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...